A carregar...
Teasing out the best molecular marker in the AKT/MTOR pathway in HNSCC patients
OBJECTIVES: No reliable molecular biomarker is currently available for clinical application in the management of head and neck cancer patients. The AKT/MTOR pathway is activated in 90-100% of HNSCC and could be promising biomarkers closely linked to cancer incidence. METHODS: Oral mucosa from non-ca...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2997737/ https://ncbi.nlm.nih.gov/pubmed/20513033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/lary.20917 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|